EmpNia, a Minneapolis-based medical device innovator, has received FDA clearance to market its eMotus system for managing respiratory motion in image-guided radiation therapy (IGRT). The breakthrough technology consists of a single-use disposable sensor pad and software that provides real-time respiratory motion tracking for cancer patients undergoing radiation treatment.
Addressing Critical Clinical Challenges
Managing respiratory motion remains a significant obstacle in delivering safe and precise image-guided radiation therapy. Current market solutions present multiple limitations, including difficulty of use, disruption to clinical workflows, ineffectiveness for many patient presentations, incompatibility across various imaging and therapy modalities, and high capital investment requirements for installation and maintenance.
"Effectively managing respiratory motion across all patient types and delivery systems, whether during imaging or radiation therapy, has long challenged clinicians and added unnecessary time and complexity," said Dr. Cliff Robinson, Chief Medical Officer of EmpNia Inc.
System Design and Capabilities
The eMotus system addresses these barriers through its streamlined design that sets up in minutes and installs within hours. The technology provides intuitive, real-time respiratory motion tracking for all patient types while maintaining universal compatibility with existing imaging and therapy equipment. This compatibility enables clinics to adopt advanced motion management without requiring costly infrastructure investments.
In pre-market evaluations, eMotus demonstrated significant improvements in workflow efficiency, setup simplicity, and motion tracking accuracy across all clinical presentations. The straightforward disposable design reduces staff burden and eliminates the need for capital-intensive installations and maintenance contracts.
Market Impact and Accessibility
"Radiation oncology teams shouldn't have to choose between precision and practicality," said Manojeet Bhattacharya, Founder and CEO of EmpNia Inc. "With FDA clearance of eMotus, we are delivering a motion management system that is easy to use, works for all patient types, integrates seamlessly with any setup, and is cost-effective thanks to our disposable sensor pad model."
The system is intended for use by radiation oncology professionals managing patients undergoing image-guided radiation therapy who require monitoring and management of respiratory motion during treatment. Bhattacharya's vision centers on making precision radiation therapy accessible in every care setting through this cost-effective approach.
Company Background
Founded in 2020, EmpNia emerged from Bhattacharya's extensive background in scientific research and medical imaging innovation. After leading technology development in molecular imaging at a healthcare conglomerate, he identified a critical gap in motion management solutions for radiation therapy and developed eMotus to address this unmet need.
The Minneapolis-headquartered company focuses on developing innovative, practical, and universally accessible medical technologies that solve persistent challenges in radiation therapy and diagnostic imaging.
